August 2025
1. LI Y, McIntosh J, Jiang V, Yan F, et al
   BCL-2/BCL-X(L) dual inhibition triggers Gasdermin D-mediated pyroptosis in mantle cell lymphoma.
   Cancer Lett. 2025;632:217961.
   

   >> Share

   
   March 2025
2. WANG Y, Liu W, Gu Z, Chang Y, et al
   Allogeneic versus autologous hematopoietic stem cell transplantation for adult T-lymphoblastic lymphoma: a real-world multicenter analysis in China.
   Cancer Lett. 2025 Mar 21:217664. doi: 10.1016/j.canlet.2025.217664.
   

   >> Share

   
   
3. CAO J, Hu D, Yu H, Xie Y, et al
   Interleukin-2-inducible T-cell kinase inhibition to block NF-kappaB signaling exerts anti-tumor effect and enhances chemotherapy in NK/T-cell lymphoma.
   Cancer Lett. 2025 Mar 5:217602. doi: 10.1016/j.canlet.2025.217602.
   

   >> Share

   
   February 2025
4. WANG J, Dong L, Xu L, Chu ES, et al
   Corrigendum to "B cell CLL/lymphoma 6 member B inhibits hepatocellular carcinoma metastases in vitro and in mice" [Cancer Lett. 355 (2014) 192-200].
   Cancer Lett. 2025 Feb 25:217564. doi: 10.1016/j.canlet.2025.217564.
   

   >> Share

   
   July 2024
5. LI B, Adam Eichhorn PJ, Chng WJ
   Targeting the ubiquitin pathway in lymphoid malignancies.
   Cancer Lett. 2024;594:216978.
   

   >> Share

   
   June 2024
6. WANG Y, Chen J, Gao Y, Chai KXY, et al
   CDK4/6 inhibition augments anti-tumor efficacy of XPO1 inhibitor selinexor in natural killer/T-cell lymphoma.
   Cancer Lett. 2024;597:217080.
   

   >> Share

   
   
7. WU S, Wang H, Yang Q, Liu Z, et al
   METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth.
   Cancer Lett. 2024 Jun 14:217058. doi: 10.1016/j.canlet.2024.217058.
   

   >> Share

   
   May 2024
8. HU D, Cao J, Yu H, Ding N, et al
   PI3K inhibitor idelalisib enhances the anti-tumor effects of CDK4/6 inhibitor palbociclib via PLK1 in B-cell lymphoma.
   Cancer Lett. 2024 May 28:216996. doi: 10.1016/j.canlet.2024.216996.
   

   >> Share

   
   April 2024
9. LIANG JH, Wang WT, Wang R, Gao R, et al
   PRMT5 activates lipid metabolic reprogramming via MYC contributing to the growth and survival of mantle cell lymphoma.
   Cancer Lett. 2024;591:216877.
   

   >> Share

   
   January 2024
10. WANG WT, Xing TY, Du KX, Hua W, et al
    CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
    Cancer Lett. 2024 Jan 9:216616. doi: 10.1016/j.canlet.2024.216616.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share